Manufacturing

Working together affords many unseen opportunities for pharmaceutical innovation.

Fixed-dose combination drug therapies give rise to innovation in solid-dosage formulations and manufacturing.

Measuring the size of the market for contract manufacturing services requires a careful hand.

Q&A with David Elder and Richard Wright of Strategic Compliance Consulting, PAREXEL International. Both Elder and Wright formerly served with FDA.

The physical form of an API is an important consideration in formulation development. Particle-engineering technologies, such as crystal design for controlling crystallisation and producing cocrystals, particle-size reduction and amorphous solid dispersions, help to optimise delivery of a drug.

Watson Laboratories has recalled two lots of hydrocodone bitartrate and acetaminophen tablets.

Foaming can be used to improve processing in the extruder without the use of a plasticizer, facilitate milling, increase dissolution rates, and produce novel dosage forms.

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the September 2012 edition from Uhlmann Packaging Systems and GE Healthcare.

Critical process parameters must be considered to optimize manufacturing of topical dosage forms.

Bristol-Myers Squibb has initiated a voluntary recall of 10 lots of BiCNU (carmustine for injection) previously manufactured by Ben Venue Laboratories, a former, third-party contract manufacturer for the company, to the user level.

Generic-drug manufacturers are preparing to pay fees to FDA for the first time in the agency’s history.

The advantages and disadvantages of hot-melt extrusion in solid dispersion formulations.

Q&A on GDUFA implementation with Aloka Srinivasan, PhD, a principal consultant with Parexel and former team leader in FDA's Office of Generic Drugs.

A review of taints and odors in the pharmaceutical and consumer healthcare industries.

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development, with a focus on stability.

Packaging and monitoring tools protect temperature-sensitive pharmaceuticals.

Ties between the biotechnology industry and university research are crucial.

International trade can be great for business, but breaking border laws can put one in hot water.

Industry experts share perspectives on analytical instrumentation, methods, and data analysis.

Industry and academia advance novel approaches for achieving enanioselectivity.

New product reviews for September 2012, featuring products for manufacturing.

Import controls and risk strategies aim to promote quality and spur new drug development.

Brazil takes first steps towards gaining quality requirements for pharmaceutical excipients.

MIT survey results address product and site characteristics that statistically correlate with quality performance.

The authors investigate the tablet-coating process using a combination of different simulation techniques.